HL192 well tolerated in volunteers in Parkinson’s clinical trial
HL192, an experimental oral therapy being developed to treat Parkinson’s disease, was tolerated well by healthy volunteers in a…
Articles by Marisa Wexler, MS
Chaperone proteins may help lower alpha-synuclein in Parkinson’s
Higher levels of proteins called chaperones are linked with lower levels of disease-driving toxic protein clumps in the brains of…
Side-to-side eye movement can improve stability in Parkinson’s
Side-to-side eye movements can help reduce body sway and improve postural stability in people with Parkinson’s disease, even though…
Cleveland Clinic named Parkinson’s Foundation Center of Excellence
The Cleveland Clinic’s Center for Neurological Restoration, which specializes in medical and surgical approaches for treating Parkinson’s disease and…
Air pollution raises patients’ risk of hospitalization, study finds
People with Parkinson’s disease who live in areas with measurable air pollution are at a heightened risk of hospitalization,…
Speech changes before, after diagnosis evident in celebrities
Analyzing vocal recordings could help in detecting Parkinson’s disease at early stages, according to a study that tested the…
Gut bacteria may be useful markers for diagnosing Parkinson’s: Analysis
Changes in gut bacteria may be a useful marker to help diagnose Parkinson’s disease, according to a new analysis.
Genetics that control size of brain regions linked with Parkinson’s risk
Genetic variations that influence the size of specific brain regions are associated with an increased risk of developing Parkinson’s…
System uses sensors, machine learning to detect Parkinson’s
Integrating wearable sensors and machine learning has enabled researchers to develop a simplified method to diagnose Parkinson’s disease. The…
Genetic counselors can be sources of emotional support in Parkinson’s
Providing emotional support is a key part of a genetic counselor’s role — but many people with Parkinson’s disease…